ArticleDiabetologia2026

Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention - Immune Tolerance trial.

Hanna Samuelsson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.